Search results for " vaccine"

showing 10 items of 680 documents

Attitudes of Healthcare Personnel towards Vaccinations before and during the COVID-19 Pandemic

2021

Vaccines constitute highly effective tools for controlling and eliminating vaccine-preventable diseases (VPDs) and are assessed to avert between two to three million deaths per year globally. Healthcare personnel (HCP) constitute a priority group for several vaccinations. However, studies indicate significant rates of vaccine hesitancy among them and, therefore, of acceptance of vaccination recommendations. This cross-sectional study was conducted in a university hospital in Southern Italy to assess the knowledge and attitudes of HCP about VPDs before and during the COVID-19 pandemic, estimate their intention to get vaccinated against COVID-19, and search for determinants that may influence…

2019-20 coronavirus outbreakHealth Knowledge Attitudes PracticeknowledgeCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Cross-sectional studyOccupational riskHealth Toxicology and MutagenesisCOVID-19 Vaccinelcsh:MedicineArticle03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesEnvironmental healthHealth carePandemicoccupational riskHumansMedicineSurveys and Questionnaire030212 general & internal medicinePandemicsCross-Sectional Studie0303 health sciencesattitudes030306 microbiologybusiness.industrySARS-CoV-2lcsh:RPublic Health Environmental and Occupational HealthCOVID-19University hospitalvaccinationVaccinationCross-Sectional StudiesAttitudeItalyPandemics.vaccine hesitancybusinessHumanhealthcare personnelInternational Journal of Environmental Research and Public Health
researchProduct

Racing for a SARS‐CoV‐2 vaccine

2021

Interview with EMBO Members Özlem Türeci and Uğur Şahin, BioNTech, conducted by science journalist Kai Kupferschmidt.

2019-20 coronavirus outbreakMedicine (General)COVID-19 VaccinesCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyCOVID-19QH426-470VirologyR5-920GeneticsHumansMolecular MedicineMedicineInterviewbusinessEMBO Molecular Medicine
researchProduct

Atypical thrombosis associated with VaxZevria (R) (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres

2021

The current COVID-19 pandemic is an exceptional health situation including for drug use. As there was no known effective drug for COVID-19 at the beginning of the pandemic, different candidates were proposed. In this short article, we present the French public pharmacovigilance activities during this health crisis. Although COVID-19 is a confounding factor per se, owing to its potential for multi-organ damage including the heart and kidney, the quality of the transmitted data in adverse drug reaction reports, the timeliness of feedback from clinicians, and the real-time pharmacological and medical analysis by the French network of the regional pharmacovigilance centers made it possible to s…

2019-20 coronavirus outbreakTime FactorsCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)[SDV]Life Sciences [q-bio]Letter to EditorAntiviral AgentsPharmacovigilancePharmacovigilancemedicineAdverse Drug Reaction Reporting SystemsHumansPharmacology (medical)PandemicsComputingMilieux_MISCELLANEOUSCovid-19 vaccineSARS-CoV-2business.industryCOVID-19VaxZevria®medicine.diseaseAtypical thrombosisThrombosisVirology[SDV] Life Sciences [q-bio]Anti-PF4 antibodiesFrancebusinessThrombopenia
researchProduct

Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey

2021

2019-20 coronavirus outbreakmedicine.medical_specialtyCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Cross-sectional studySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Directive CounselingInternal medicineHumansImmunology and AllergyMedicineFamilyPhysician's RoleLetter to the EditorAcademicSubjects/MED00260Ibdjnl/1SARS-CoV-2business.industryGastroenterologistsVaccinationAge FactorsGastroenterologyCOVID-19Inflammatory Bowel DiseasesPatient Acceptance of Health CareInflammatory Bowel DiseasesVaccinationItalyInfluenza VaccinesCohortbusinessAttitude to HealthInflammatory Bowel Diseases
researchProduct

Urology practice during the COVID-19 vaccination campaign

2021

Introduction: The current scenario of the COVID-19 pandemic is significantly different from that of the first, emergency phase. Several countries in the world are experiencing a second, or even a third, wave of contagion, while awaiting the effects of mass vaccination campaigns. The aim of this report was to provide an update of previously released recommendations on prioritization and restructuring of urological activities. Methods: A large group of Italian urologists directly involved in the reorganization of their urological wards during the first and second phase of the pandemic agreed on a set of updated recommendations for current urology practice. Results: The updated recommendations…

2019-20 coronavirus outbreakmedicine.medical_specialtyCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronaviru030232 urology & nephrologycoronavirusmedicine.disease_causesurgery03 medical and health sciences0302 clinical medicinevaccinePandemicmedicineHumansOriginal Research Articlecoronavirus; COVID-19; pandemic; vaccine; urology; clinical practice guidelines; surgery; endourologyurologyPandemicsCoronavirusbusiness.industryImmunization ProgramsSARS-CoV-2pandemicendourologyCOVID-19General MedicineVirologySmart communication (SC173–SC181) Urinary stones: timing and assessmentVaccination030220 oncology & carcinogenesisEmergency medicineUrologic Surgical ProceduresCOVID-19; Coronavirus; clinical practice guidelines; endourology; pandemic; surgery; urology; vaccinebusinessclinical practice guidelinesclinical practice guideline
researchProduct

Pertussis vaccines--1993.

1993

AdolescentWhooping CoughJapanmedicinemedia_common.cataloged_instanceHumansEuropean UnionEuropean unionChildWhooping coughDiphtheria-Tetanus-Pertussis Vaccinemedia_commonPertussis Vaccinebusiness.industryInfant NewbornInfantDiphtheria-Tetanus-Pertussis Vaccinemedicine.diseaseInfant newbornVaccinationEuropeChild PreschoolPediatrics Perinatology and Child HealthImmunologyPertussis vaccinebusinessTos ferinamedicine.drugForecastingEuropean journal of pediatrics
researchProduct

Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection

2021

Reactivation of latent cytomegalovirus (CMV) endangers the therapeutic success of hematopoietic cell transplantation (HCT) in tumor patients due to cytopathogenic virus spread that leads to organ manifestations of CMV disease, to interstitial pneumonia in particular. In cases of virus variants that are refractory to standard antiviral pharmacotherapy, immunotherapy by adoptive cell transfer (ACT) of virus-specific CD8+ T cells is the last resort to bridge the “protection gap” between hematoablative conditioning for HCT and endogenous reconstitution of antiviral immunity. We have used the well-established mouse model of CD8+ T-cell immunotherapy by ACT in a setting of experimental HCT and mu…

Adoptive cell transfermedicine.medical_treatmentImmunologyCytomegalovirusCD8-Positive T-LymphocytesLymphocyte ActivationCD8+ T cellsVirusCytomegalovirus VaccinesImmunocompromised HostAntigenvaccineMHC class ImedicineImmunology and AllergyCytotoxic T cellAnimalsCells Culturedadoptive cell transferCell ProliferationOriginal ResearchHCMV dense bodiesbiologybusiness.industryVaccinationHematopoietic Stem Cell TransplantationImmunotherapyRC581-607VirologyAdoptive TransferTransplantationMice Inbred C57BLantiviral protectionT cell primingDisease Models AnimalT cell receptor transgenic cellsCytomegalovirus InfectionsHost-Pathogen Interactionsbiology.proteinFemaleVirus Activationsubviral particlesImmunologic diseases. AllergybusinessCD8Frontiers in Immunology
researchProduct

Interleukin-7 or Interleukin-15 Enhances Survival ofMycobacterium tuberculosis-Infected Mice

2000

ABSTRACTBoth antigen-presenting cells and immune effector cells are required to effectively eradicate or containMycobacterium tuberculosis-infected cells. A variety of cytokines are involved to ensure productive “cross talk” between macrophages and T lymphocytes. For instance, infection of macrophages with mycobacteria leads to effective interleukin-7 (IL-7) and IL-15 secretion, and both cytokines are able to maintain strong cellular immune responses of α/β and γ/δ T cells. Here we show that either cytokine is able to enhance survival ofM. tuberculosis-infected BALB/c mice significantly compared to application of IL-2, IL-4, or phosphate-buffered saline (as a control). Enhanced survival cou…

Adoptive cell transfermedicine.medical_treatmentImmunologySpleenBiologyMicrobiologyMiceImmune systemmedicineAnimalsTuberculosisInterleukin-15Mice Inbred BALB CInterleukin-7InterleukinMycobacterium tuberculosisT lymphocyteAdoptive TransferDisease Models AnimalInfectious Diseasesmedicine.anatomical_structureCytokineInterleukin 15Microbial Immunity and VaccinesImmunologyCytokinesFemaleParasitologyTumor necrosis factor alphaSpleenInfection and Immunity
researchProduct

Invasive meningococcal disease in Italy: from analysis of national data to an evidence-based vaccination strategy

2020

Introduction. Invasive meningococcal disease (IMD) is one of the most severe vaccine-preventable diseases not yet under control. In Italy, although different anti-meningococcal vaccines are available, their offer among regions is heterogeneous. The aim of this study is to describe the epidemiology of IMD in Italy based on analysis of national surveillance data for 2011–2017 to optimize the vaccination strategy. Methods: IMD surveillance data from the Italian National Health Institute were analysed. Microsoft Excel was used to present trend analysis, stratifying by age and serogroups. Results: In Italy, during the period 2011–2017, the incidence of IMD increased from 0.25 cases/100,000 inhab…

AdultAdolescentDatabases FactualInvasive meningococcal diseasesEpidemiologyMeningococcal VaccinesNO03 medical and health sciencesYoung AdultInvasive meningococcal diseases • epidemiology • surveillance system • anti-meningococcal vaccination strategiesHumansChildSurveillance system0303 health sciencesEvidence-Based Medicine030306 microbiologyInvasive meningococcal diseases Epidemiology Surveillance system Anti-meningococcal vaccination strategiesIncidenceInvasive meningococcal diseaseInfantMiddle AgedMeningococcal InfectionsItalyChild PreschoolPopulation SurveillanceOriginal ArticleAnti-meningococcal vaccination strategiesanti-meningococcal vaccination strategies.Journal of Preventive Medicine and Hygiene
researchProduct

[Alert for meningitis in Palermo? Successful strategies to counteract the impact of mass media]

2018

Following two invasive meningococcal disease cases among twenties, general population overloaded vaccination Units of the Palermo's District during summer 2016. Sicilian Health Authorities adopted several public health strategies including: a) active meningococcal vaccination free of charge for people from 18 up to 30 years of age, b) information in crowded places and rapid communication by media. An increase in anti-meningococcal vaccination doses administered (+868%) as well as in anti-dTp and HPV vaccination (+41% and +8%, respectively) due to a further catch-up was observed.

AdultAdolescentVaccinationInfantMeningococcal Vaccinesinvasive meningococcal disease active meningococcal vaccination public health strategiesMeningitis MeningococcalMiddle AgedYoung AdultItalyChild PreschoolHumansMass MediaPublic HealthChildAged
researchProduct